Sarcopenia: Diagnosis and treatment

Journal of Nutrition, Health and Aging

Volumn 12, Issue 7, 2008, Pages 452-456

  Morley, J E ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMYOSTATIN; CASEIN; CREATINE; CREATININE; GHRELIN AGONIST; GROWTH HORMONE DERIVATIVE; LEUCINE; NANDROLONE; OSTARINE; PERINDOPRIL; PLACEBO; PRASTERONE; PROTEIN ANTIBODY; SELECTIVE ANDROGEN RECEPTOR MODULATOR; TESTOSTERONE; TOPIRAMATE; VITAMIN D;

AEROBIC CAPACITY; ANOREXIA; ANTHROPOMETRY; ARTICLE; CACHEXIA; CALORIC INTAKE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIETARY INTAKE; DRUG DOSE REGIMEN; DRUG MEGADOSE; DUAL ENERGY X RAY ABSORPTIOMETRY; EXERCISE; FATIGUE; HUMAN; IMPEDANCE; MUSCLE ATROPHY; MUSCLE MASS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN INTAKE; WEIGHT REDUCTION;

EID: 50049120029     PISSN: 12797707     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02982705     Document Type: Article

References (93)

1. Critchley M. The neurology of old age. Nutrition. 2001;17:660-663.
2. Rosenberg IH. Sarcopenia: Origins and clinical relevance. J Nutr. 1997;127(Suppl 5):S990-S991.
3. Morley JE. Anorexia, sarcopenia, and aging. Nutrition. 2001;17:660-663.
4. Rolland YM, Perry HM 3rd, Patrick P, et al., Loss of appendicular muscle mass and loss of muscle strength in young postmenopausal women. J Gerontol A Biol Sci Med Sci. 2007;62:330-335.
5. Baumgartner RN, Koehler KM, Gallagher D, et al., Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998;147:755-763.
6. Morley JE, Baumgartner RN, Roubenoff R, et al., Sarcopenia. J Lab Clin Med. 2001;137:231-243.
7. Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc. 2002;50:889-896.
8. Tanko LB, Movsesyan L, Mouritzen U, Christiansen C, Svendsen OL. Appendicular lean tissue mass and the prevalence of sarcopenia among healthy women. Metabolism. 2002;51:69-74.
9. Melton LJ, Khosla S, Crowson CS, O'Connor MD, O'Fallon WM, Riggs BL. Epidemiology of sarcopenia. J Am Geriatr Soc. 2000;48:625-630.
10. Gillette-Guyonnet S, Hourhashemi F, et al., Body composition in French women 75+ years of age: the EPIDOS study. Mech Ageing Dev. 2003;124:311-316.
11. Castillo EM, Goodman-Gruen D, Kritz-Silverstein D, et al., Sarcopenia in elderly men and women: The Rancho Bernardo Study. Am J Prev Med. 2003;25:226-231.
12. Ianuzzi-Sucich M, Prestwood KM, Kenny AM. Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women. J Gerontol A Biol Sci Med Sci. 2002;57:M2771-M777.
13. Morley JE, Kim MJ, Haren MT, Kevorkian R, Banks WA. Frailty and the aging male. Aging Male. 2005;8:135-140.
14. Janssen I, Shepard DS, Katzmarzyk PT, Roubenoff R. The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc. 2004;52:80-85.
15. Baumgartner RN, Wayne SJ, Waters DL et al., Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly. Obes Res. 2004;12:1995-2004.
16. Goodpaster BH, Carlson CL, Visser M, et al., Attenuation of skeletal muscle and strength in the elderly: The Health ABC Study. J Appl Physiol. 2001;90:2157-2163.
17. Larsson L. Histochemical characteristics of human skeletal muscle during aging. Acta Physiol Scand. 1983;117:469-471.
18. Reeves ND, Narici MB, Maganaris CN. Myotendinous plasticity to ageing and resistance exercise in humans. Exp Physiol. 2006;91:483-498.
19. Narici MV, Maganaris CN. Adaptability of elderly human muscles and tendons to increased loading. J Anat. 2006;208:433-443.
20. Thomas DR, Ashmen W, Morley JE, Evans WJ. Nutritional management in long-term care: development of a clinical guideline. Council for Nutritional Strategies in Long-Term Care. J Gerontol A BIol Sci Med Sci. 2000;55:M725-M734.
21. Morley JE. Weight loss in the nursing home. J Am Med Dir Assoc. 2007;8:201-204.
22. Morley JE. Weight loss in older persons: new therapeutic approaches. Curr Pharm Des. 2007;13:3637-3647.
23. Morley JE. Anorexia and weight loss in older persons. J Gerontol A Biol Sci Med Sci. 2003;58:131-137.
24. Morley JE, Thomas DR, Wilson MM. Cachexia: pathophysiology and clinical relevance. Am J Clin Nutr. 2006;83:735-743.
25. Thomas DR, Cote TR, Lawhorne L, et al., Understanding clinical dehydration and its treatment. J Am Med Dir Assoc. 2008;9: june issue (In Press)
26. Kalantar-Zadeh K, Horwich TB, Oreopoulos A, et al., Risk factor paradox in wasting diseases. Curr Opin Clin Nutr Metab Care. 2007;10:433-442. 27 Manini TM, Everhart JE, Patel KV, et al. Daily activity energy expenditure and mortality among older adults. JAMA. 2006;296:171-179.
27. Hughes VA, Roubenoff R, Wood M, et al., Anthropometric assessment of 10-y changes in body composition in the elderly. Am J Clin Nutr. 2004;80:475-482.
28. Kortebien P, Ferrando A, Lombeida J, et al., Effect of 1 days of bed rest on skeletal muscle in healthy older adults. JAMA. 2007;297:1772-1774.
29. Roubenoff R. Physical activity, inflammation, and muscle loss. Nutr Rev. 2007;65(12 Pt 2):S208-S212.
30. Frankel JE, Bean JF, Frontera WR. Exercise in the elderly: research and clinical practice. Clin Geriatr Med. 2006;22:239-256.
31. Singh MA. Exercise to prevent and treat functional disability. Clin Geriatr Med. 2002;18:431-462.
32. Heath JM, Stuart MR. Prescribing exercise for frail elders. J Am Board Fam Pract. 2002;15:218-228.
33. van Kan GA, Rolland YM, Morley JE, Vellas B. Frailty: toward a clinical definition. J Am Med Dir Assoc. 2008;9:71-72.
34. Kotz CM, Wang C, Teske JA, et al. Orexin A mediation of time spent moving in rats: neural mechanisms. Neuroscience. 2006;342:29-36.
35. Simonsick EM, Guralnik JM, Volpato S, et al., Just get out the door! Importance of walking outside the home for maintaining mobility; findings from the women's health and aging study. J Am Geriatr Soc. 2005;53:198-203.
36. Bartali B, Frongillo EA, Bandinelli S, et al. Low nutrient intake is an essential component of frailty in older persons. J Gerontol A Biol Sci Med Sci. 2006;61:589-593.
37. Chapman IM, MacIntosh CG, Morley JE, Horowitz M. The anorexia of ageing. Biogerontology. 2002;3:67-71.
38. Hays NP, Roberts SB. The anorexia of aging in humans. Physiol Behav. 2006;88:257-266.
39. Morley JE. Decreased food intake with aging. J Gerontol A Biol Sci Med Sci. 2001;56(Spec 2):81-88. 41 Morley JE. Weight loss in the nursing home. J Am Med Dir Assoc. 2007;8:201-204.
40. Morley JE. Kraenzle D. Causes of weight loss in a community nursing home. J Am Geriatr Soc. 1994;42:583-585.
41. Cabrera MA, Mesas AE, Garcia AR, de Andrade SM. Malnutrition and depression among community-dwelling elderly people. J Am Med Dir Assoc. 2007;8:582-584.
42. Volpi E, Sheffield-Moore M, Rasmussen BB, Wolfe RR. Basal muscle amino acid kinetics and protein synthesis in healthy young and older men. JAMA. 2001;286:1206-1212.
43. Paddon-Jones D, Sheffield-Moore M, Urban RJ, et al. Essential amino acid and carbohydrate supplementation ameliorates muscle protein loss in humans during 28 days bedrest. J Clin Endocrinol Metab. 2004;89:4351-4358.
44. Candow DG, Chilibeck PD. Effect of creatine supplementation during resistance training on muscle accretion in the elderly. J Nutr Health Aging. 2007;11:185-188.
45. Olsen S, Aagaard P, Kadi F, et al. Creatine supplementation augments the increase in satellite cell and myonuclei number in human muscle induced by strength training. J Physiol. 2006;573(Pt 2):525-534.
46. Morley JE, Kaiser FE, Perry HM 3rd, et al., Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. Metabolism. 1997;46:410-413.
47. Feldman HA, Longcope C, Derby CA, et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrionl Metab. 2002;87:589-598.
48. Morley JE, Perry HM 3rd. Androgens and women at the menopause and beyond. J Gerontol A BIol Sci Med Sci. 2003;58:M409-M416.
49. Morley JE. The diagnosis of late life hypogonadism. Aging Male. 2007;10:217-220.
50. Wittert GA, Chapman IM, Haren MT, et al., Oral testosterone supplementation increases muscle and decreases fat mass in healthy elderly males with low-normal gonadal status. J Gerontol A Biol Sci Med Sci. 2003;58:618-625.
51. Snyder PJ, Peachey H, Hannoush P, et al., Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age. J Clin Endocrinol Metab. 1999;84:2647-2653.
52. Morley JE, Perry HM 3rd, Kaiser FE, et al. Effects of testosterone replacement therapy in old hypogonadal males: a preliminary study. J Am Geriatr Soc. 1993;41:149-152.
53. Ottenbacher KJ, Ottenbacher ME, Ottenbacher AJ, et al. Androgen treatment and muscle strength in elderly men: a meta-analysis. J Am Geriatr Soc. 2006;54:1666-1673.
54. Sih R, Morley JE, Kaiser FE, et al. Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial. J Clin Endocrinol Metab. 1997;82:1661-1667.
55. Page ST, Amory JK, Bowman FD, et al. Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T. J Clin Endocrinol Metab. 2005;90:1502-1510.
56. Bhasin S, Taylor WE, Singh R, et al. The mechanisms of androgen effects of body composition: mesenchymal pluripotent cellas the target of androgen action. J Gerontol A Biol Sci Med Sic. 2003;58:M1103-M1110.
57. Chapman IM. Anorexia abstracts, 4th Cachexia Conference. Tampa, Florida, March 1, 2007. www.cachexia.org
58. Haren MT, Malmstrom TK, Banks WA, et al. Lower serum DHEAs levels are associated with a higher degree of physical disability and depressive symptoms in middle-aged to older African American women. Maturitas. 2007;57:347-360.
59. Percheron G, Hogrel JY, Denot-Ledunois S, et al. Effect of 1-year oral administration of dehydroepiandrosterone to 60- to 80-year-old individuals on muscle function and cross-sectional area: a double-blind placebo-controlled trial. Arch Intern med. 2003;163:720-727.
60. Frisoli A Jr., Chaves PH, Pinheiro MM, Szejnfeld VL. The effect of nandrolone decanoate on bone mineral density, muscle mass, and hemoglobin levels in elderly women with osteoporosis: a double-blind, randomized, placebo-controlled clinical trial. J Gerontol A Biol Sci Med Sci. 2005;60:648-653.
61. MacDonald JH, Marcora SM, Jibani MM, et al., Nandrolone decanoate as anabolic therapy in chronic kidney disease: a randomized phase II dose-finding study. Nephron Clin pract. 2007;106:c125-c135.
62. Gold J, Batterham MJ, Rekers H, et al. Effects of nandrolone decanoate compared with placebo or testosterone on HIV-associated wasting. HIV Med. 2006;7:146-155.
63. Creutzberg EC, Wouters EF, Mostert R, et cl. A role for anabolic steroids in the rehabilitation of patients with COPD? A double-blind, placebo-controlled, randomized trial. Chest. 2003;124:1733-1742.
64. Gao W, Dalton JT, Ockham's razor and selective androgen receptor modulators (SARMs): are we overlooking the role of 5alpha-reductase? Mol Interv. 2007;7:10-13.
65. Evans WJ, Smith M, Morley JE, et al. Ostarine increases lean body mass and improves physical performance in healthy elderly subjects: Implications for cancer cachexia patients. 2007 Annual Meeting Proceedings Part I. J Clin Oncol 2007;25(18S):9119.
66. Visser M, Deeg DJH, Lips P. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): The Longitudinal Aging Study Amsterdam. J Clin Endocrin Metab. 2003;88:5766-5772.
67. Morley JE. Should all long-term care residents receive vitamin D? J Am Med Dir Assoc. 2007;8:69-70.
68. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, et al. Effect of vitamin D on falls: a meta-analysis. JAMA. 2004;291:1999-2006.
69. Heath KM, Elovic EP. Vitamin D deficiency: implications in the rehabilitation setting. Am J Phys Med Rehabil. 2006;85:916-923.
70. Perry HM 3rd, Horowitz M, Morley JE, et al. Longitudinal changes in serum 25-hydroxyvitamin D in older people. Metabolism. 1999;48:1028-1032.
71. Drinka PJ, Krause PF, Nest LJ, Goodman BM. J Am Med Dir Assoc. 2007;8:76-79.
72. Hamid Z, Riggs A, Spencer T, Redman C, Bodenner D. Vitamin D deficiency in residents of academic long-term care facilities despite having been prescribed vitamin D. J Am Med Dir Assoc. 2007;8:71-75.
73. Munir J, Wright RJ, Carr DB. A quality improvement study on calcium and vitamin D supplementation in long-term care. J Am med Dir Assoc. 2006;7:305-309.
74. Chu LW, Lam KS, Tam SC et al. A randomized controlled trial of low-dose recombinant human growth hormone in the treatment of malnourished elderly medical patients: J Clin Endocrinol Metab. 2001;86:1913-1920.
75. Kaiser FE, Silver AJ, Morley JE. The effect of recombinant human growth hormone on malnourished older individuals. J Am Geriatr Soc. 1991;39:235-240.
76. Morley JE. Growth hormone: fountain of youth or death hormone? J Am Geriatr Soc. 1999;47:1475-1476.
77. Gaskin FS, Farr SA, Banks WA, et al. Ghrelin-induced feeding is dependent on nitric oxide. Peptides. 2003;24:913-918.
78. Diano S, Farr SA, Benoit SC, et al. Ghrelin controls hippocampal spine synapse density and memory performance. Nat Neurosci. 2006;9:381-388.
79. Nagaya N, Moriya J, Yasumura Y, et al. Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure. Circulation. 2004;110:3674-3679.
80. Carter CS, Onder G, Kritchevsky SB, Pahor M. Angiotensin-converting enzyme inhibition intervention in elderly persons: effects on body composition and physical performance. J Gerontol A Biol Sci Med Sci. 2005;60:1437-1446.
81. Onder G, Vedova CD, Pahor M. Effects of ACE inhibitors on skeletal muscle. Curr Pharm Des. 2006;12:2057-2064.
82. Frederiksen H, Bathum L, Worm C, et al. ACE genotype and physical training effects: a randomized study among elderly Danes. Aging Clin Exp Res. 2003;15:284-291.
83. Sumukadas D, Witham MD, Struthers AD, McMurdo ME. Effect of perindopril on physical function in elderly people with functional impairment: a randomized controlled trial. CMAJ. 2007;177:867-874.
84. Hutcheon SD, Gillespie ND, Crombie IK, Struthers AD, McMurdo ME. Perindopril improves six minute walking distance in older patients with left ventricular systolic dysfunction: a randomized double blind placebo controlled trial. Heart. 2002;88:373-377.
85. Ferrucci L, Penninx BWJH, Volpato S, et al. Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels. J Am Geriatr Soc. 2002;50:1947-1954.
86. Ershler WB, Keller ET. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Ann Rev Med. 2000;51:245-270. 89 Morley JE, Baumgartner RN. Cytokine-related aging process. J Gerontol A BIol Sci Med Sci. 2004;59:M924-M929.
87. McNally EM. Powerful genes - myostatin regulation of human muscle mass. N Engl J Med. 2004;350:2642-2644.
88. Mazza AD, Morley JE. Metabolic syndrome and the older male population. Aging Male. 2007;10:3-8.
89. Mazza AD, Morley JE. Update on diabetes in the elderly and the application of current therapeutics. J Am Med Dir Assoc. 2007;8:489-492.
90. Patel S, Hyer S, Tweed K, et al. Risk factors for fractures and falls in older women with type 2 diabetes mellitus. Calcif Tissue Int. 2008;82:87-91.
91. Doherty TJ, Vandervoort AA, Brown WF. Effects of ageing on the motor unit: a brief review. Can J Appl Physiol. 1993;18:331-358.
92. Guillet C, Auguste P, Mayo W, et al. Ciliary neurotrophic factor is a regulator of muscular strength in aging. J Neurosci. 1999;19:1257-1262.
93. Morley JE, Patrick P, Perry HM 3rd. Evaluation of assays available to measure free testosterone. Metabolism. 2002;51:554-559.